CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label, Single-arm, Phase IV Study Assessing the Immunogenicity and Safety of ZOSTAVAX® at Minimum Release Specification Approaching Expiry Potency in Subjects ≥50 Years Old.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00681031
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:07.496775+00:00
Published At: 2017-09-26T00:00:00+00:00
Record Updated At: 2021-06-29
Results Posted At: 2017-09-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Herpes Zoster"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-06-29"
protocolSection.identificationModule.nctId: "NCT00681031"
protocolSection.identificationModule.officialTitle: "An Open-label, Single-arm, Phase IV Study Assessing the Immunogenicity and Safety of ZOSTAVAX\u00ae at Minimum Release Specification Approaching Expiry Potency in Subjects \u226550 Years Old."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-09-26"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.